Michael Secora Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity

RXRX Quotes by TradingView

Michael Secora is Chief Financial Officer of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 1.45 Million shares of RXRX, which is worth approximately $9.29 Million. The most recent transaction as insider was on Oct 09, 2024, when has been sold 15,000 shares (Class A Common Stock) at a price of $6.36 per share, resulting in proceeds of $95,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.45M
10.2% 3M change
58.88% 12M change
Total Value Held $9.29 Million

Michael Secora Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 09 2024
SELL
Open market or private sale
$95,400 $6.36 p/Share
15,000 Reduced 1.02%
1,450,881 Class A Common Stock
Oct 09 2024
BUY
Exercise of conversion of derivative security
$87,412 $2.22 p/Share
39,375 Added 2.62%
1,465,881 Class A Common Stock
Oct 08 2024
SELL
Open market or private sale
$94,800 $6.32 p/Share
15,000 Reduced 1.04%
1,426,506 Class A Common Stock
Oct 08 2024
BUY
Exercise of conversion of derivative security
$87,412 $2.22 p/Share
39,375 Added 2.66%
1,441,506 Class A Common Stock
Sep 11 2024
SELL
Open market or private sale
$94,800 $6.32 p/Share
15,000 Reduced 1.06%
1,402,131 Class A Common Stock
Sep 11 2024
BUY
Exercise of conversion of derivative security
$87,412 $2.22 p/Share
39,375 Added 2.7%
1,417,131 Class A Common Stock
Sep 10 2024
SELL
Open market or private sale
$92,550 $6.17 p/Share
15,000 Reduced 1.08%
1,377,756 Class A Common Stock
Sep 10 2024
BUY
Exercise of conversion of derivative security
$87,412 $2.22 p/Share
39,375 Added 2.75%
1,392,756 Class A Common Stock
Aug 15 2024
SELL
Payment of exercise price or tax liability
$80,025 $6.69 p/Share
11,962 Reduced 0.88%
1,353,381 Class A Common Stock
Aug 14 2024
SELL
Open market or private sale
$95,250 $6.35 p/Share
15,000 Reduced 1.09%
1,365,343 Class A Common Stock
Aug 14 2024
BUY
Exercise of conversion of derivative security
$87,412 $2.22 p/Share
39,375 Added 2.77%
1,380,343 Class A Common Stock
Aug 13 2024
SELL
Open market or private sale
$95,250 $6.35 p/Share
15,000 Reduced 1.11%
1,340,968 Class A Common Stock
Aug 13 2024
BUY
Exercise of conversion of derivative security
$87,412 $2.22 p/Share
39,375 Added 2.82%
1,355,968 Class A Common Stock
Jul 10 2024
SELL
Open market or private sale
$108,600 $7.24 p/Share
15,000 Reduced 1.13%
1,316,593 Class A Common Stock
Jul 10 2024
BUY
Exercise of conversion of derivative security
$87,412 $2.22 p/Share
39,375 Added 2.87%
1,331,593 Class A Common Stock
Jul 09 2024
SELL
Open market or private sale
$109,800 $7.32 p/Share
15,000 Reduced 1.15%
1,292,218 Class A Common Stock
Jul 09 2024
BUY
Exercise of conversion of derivative security
$87,412 $2.22 p/Share
39,375 Added 2.92%
1,307,218 Class A Common Stock
Jun 14 2024
SELL
Open market or private sale
$139,050 $9.27 p/Share
15,000 Reduced 1.17%
1,267,843 Class A Common Stock
Jun 14 2024
BUY
Exercise of conversion of derivative security
$87,412 $2.22 p/Share
39,375 Added 2.98%
1,282,843 Class A Common Stock
Jun 13 2024
SELL
Open market or private sale
$139,800 $9.32 p/Share
15,000 Reduced 1.19%
1,243,468 Class A Common Stock
Jun 13 2024
BUY
Exercise of conversion of derivative security
$87,412 $2.22 p/Share
39,375 Added 3.03%
1,258,468 Class A Common Stock
May 15 2024
SELL
Payment of exercise price or tax liability
$119,739 $10.01 p/Share
11,962 Reduced 0.97%
1,219,093 Class A Common Stock
Apr 17 2024
SELL
Open market or private sale
$175,279 $7.58 p/Share
23,124 Reduced 1.84%
1,231,055 Class A Common Stock
Apr 17 2024
BUY
Exercise of conversion of derivative security
$83,250 $2.22 p/Share
37,500 Added 2.9%
1,254,179 Class A Common Stock
Apr 16 2024
SELL
Open market or private sale
$191,750 $7.67 p/Share
25,000 Reduced 2.01%
1,216,679 Class A Common Stock
MS

Michael Secora

Chief Financial Officer
Salt Lake City, UT

Track Institutional and Insider Activities on RXRX

Follow RECURSION PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RXRX